역류성 식도염 랫트에 미치는 金銀花 물 추출물의 치료 효과
Effects on Rats with Reflux Esophagitis Treated with Lonicerae Flos Extract
1
조회
0
다운로드
15
인용
0
참고문헌
키워드
초록
Because Lonicerae Flos has effects of antiinflammatory and antioxidant, we studied an effect of Lonicerae Flos on reflux esophagitis (RE) through those effects. Rats were treated with three different dosages of LF (500, 250 and 125 mg/kg) orally for 14 days before pylorus and forestomach ligation. Six hrs after pylorus and forestomach ligation, we dissected a stomach and examined a stomach volume, gastric acid output, pepsin release in the stomach, total hexose, sialic acid in stomach tissue and histamine contents of sera. The results were compared with an α-tocopherol (once orally, 1hr before operation, 30 mg/kg) treated group in which the effects on RE were already confirmed. Lonicerae Flos extract (LE) reduced gastric volumes compared to RE control. This indicate that LE protect a stomach mucosa by depressing of gastric acid release and corresponse with a reducing histamine content of serum. And LE decreasd a volume of pepsin in stomach compraed to RE control, LE increased contents of total hexose and sialic acid based on esophageal and gastric mucus. This indicated that an increased mucus by LE protected inflammation of esophagus mucosa and gastric mucosa induced by gastric acid. So, LE suppressed a gasric acid by decreasing a pepsin release in stomach, suppressed an injury of esophagus inducted by gastric acid with increasing esophageal mucus and a minimum dose of LE to RE was 250 mg/kg. The results suggest that antioxidant effects of LF could attenuate the severity of reflux esophagitis and prevent the esophageal mucosal damage, and validate its therapeutic use in esophageal reflux disease.
Abstract
Because Lonicerae Flos has effects of antiinflammatory and antioxidant, we studied an effect of Lonicerae Flos on reflux esophagitis (RE) through those effects. Rats were treated with three different dosages of LF (500, 250 and 125 mg/kg) orally for 14 days before pylorus and forestomach ligation. Six hrs after pylorus and forestomach ligation, we dissected a stomach and examined a stomach volume, gastric acid output, pepsin release in the stomach, total hexose, sialic acid in stomach tissue and histamine contents of sera. The results were compared with an α-tocopherol (once orally, 1hr before operation, 30 mg/kg) treated group in which the effects on RE were already confirmed. Lonicerae Flos extract (LE) reduced gastric volumes compared to RE control. This indicate that LE protect a stomach mucosa by depressing of gastric acid release and corresponse with a reducing histamine content of serum. And LE decreasd a volume of pepsin in stomach compraed to RE control, LE increased contents of total hexose and sialic acid based on esophageal and gastric mucus. This indicated that an increased mucus by LE protected inflammation of esophagus mucosa and gastric mucosa induced by gastric acid. So, LE suppressed a gasric acid by decreasing a pepsin release in stomach, suppressed an injury of esophagus inducted by gastric acid with increasing esophageal mucus and a minimum dose of LE to RE was 250 mg/kg. The results suggest that antioxidant effects of LF could attenuate the severity of reflux esophagitis and prevent the esophageal mucosal damage, and validate its therapeutic use in esophageal reflux disease.
참고문헌 (30)
- Kahrilas, P.J, "Clinical esophageal pH recording:a technical review for pracrice guideline development", Gastroenterology, 110, pp.1982~1996 (1996)
- Castell, D.O, "Review article: the pathophysiology of gastro-oesophageal reflux disease - oesophageal manifestations", Aliment Pharmacol Ther, 20(9), pp.14~25 (2004)
- Colin-Jones, D.G, "Histamine-2-receptor antagonists in gastroesophageal reflux", Gut, 30, pp.1305~1308 (1989)
- DeVault, K.R, "Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease", Am J Gastroenterol, 94, pp.1434~1440 (1999)
- Klinkenberg-Knol, E.C, "Double-blind multicentre comparison of omeprazole and ranitidine in the treatment of reflux esophagitis", Lancet, 1, pp.349~351 (1987)
- Spechler, S.J, "Comparison of medical and surgical therapy for complicated gastroesophageal reflux disease in Veteran", N Eng J Med, 326, pp.786~792 (1992)
- 全國韓醫科大學共通敎材編纂委員會, "本草學", pp.240~241 (2007), 永林社
- 김호철, "한약약리학", pp.150~152 (2001), 집문당
- 현미란, "金銀花(Lonicera japonica)추출물의 항산화 작용 연구", 순천향자연과학연구, 14(2), pp.613~167 (2008)
- pyrene 유발 간손상에 대한 간세포 보호효과, "박사", 동국대학교, 2008
- 정현우, "금은화 및 어성초가 인체 암세포주에 미치는 영향", 동의생리병리학회지, 10(1), pp.126~132 (1996)
- 이정노, "수용성 금은화 추출물이 Trimellitic Anhydride 유도 마우스 접촉성 과민반응에 미치는 영향", 대한본초학회지, 23(2), pp.51~58 (2008), 대한본초학회
- Rao, C.V, "Effect of quercetin, flavonoids and alpha-tocopherol, an antioxidant vitamin on experimental reflux oesophagitis in rats", Eur J Pharmacol, 589, pp.233~238 (2008)
- Sairam, K, "Antiulcerogenic effect of methanolic extract of Emblica officinalis : an experimental study", J. of Ethnopharmacol, 82, pp.1~9 (2002)
- Winzler, R.J, "Determination of serum glycoproteins. In Methods of Biochemical analysis", pp.279~311 (1955), Interscience Publishers Inc
- Warren, L, "The thiobarbituric acid assay of sialic acids", J Biol Chem, 234, pp.1971~1975 (1959)
- Tsuruta, Y, "Simultaneous determination of histamine and N-methyl histamine in human and rat brain by high-performance liquid chromatography with fluorescence determination", J Chromatogr, 224, pp.105~110 (1981)
- DeMeester, T.R, "Clinical and in vitro analysis of determinants of gastroesophageal competence: a study of the principles of antireflux surgery", Am J Surg, 137, pp.39~46 (1979)
- Hunt, R.H, "Importance of pH control in the management of GERD", Arch Intern Med, 159, pp.649~657 (1999)
- Inatomi, N, "Effects of a proton pump inhibitor, AG-1749 (lansoprazole), on reflux esophagitis and experimental ulcers in rats", Jpn J Pharmacol, 55, pp.437~451 (1991)
- Gartner, L.P, "Color Textbook of Histology, third edition", pp.381~411 (2007), Elsevier
- Katz, P.O, "Lessons learned from intragastric pH monitoring", J. in Gastroenterol, 33, pp.107~113 (2001)
- Wang, C, "Precise role of acid in non-erosive reflux disease", Digestion, 78(1), pp.31~41 (2008)
- Farhadi, A, "Reactive oxygen species: are they involved in the pathogenesis of GERD, Barrett's esophagus and the Latter's progression toward Esophageal cancer?", Am J Gastroenterol, 97, pp.22~26 (2002)
- Hendel, L, "Hydroxyproline in the oesophageal mucosa of patients with progressive systemic sclerosis during omeprazole-induced healing of reflux oesophagitis", Aliment Pharmcol Ther, 5, pp.471~480 (1991)
- Sillanaukee, P, "Occurrence of sialic acids in healthy humans and different disorders", Eur J Clin Investig, 29, pp.413~425 (1999)
- Brzozowski, T, "Role of gastric acid secretion in progression of acute gastric erosions induced by ischemia-reperfusion into gastric ulcers", Eur J Pharmacol, 398, pp.147~158 (2000)
- Kitano, M, "Ischemia of rat stomach mobilizes ECL cell histamine", Am J Physiol Gastrointest Liver Physiol, 288, pp.1084~1090 (2005)
- Suzuki, Y, "Antiulcer effects of antioxidant, quercetin, α-tocopherol, nifedipine and tetracycline in rats", Jpn. J. Pharmacol, 78, pp.435~441 (1998)
- Chandana Venkateswara Rao, "Effect of quercetin, flavonoids and α-tocopherol, an antioxidant vitamin on experimental reflux oesophagitis in rats", European Journal of Pharmacology, 589, pp.233~238 (2008)